S. E. Nissen{1}, L. Cho{2}, S. Nicholls{3}, S. Frndak{4}, A. Lincoff{5}, S. Tsimikas{6}, M. Blaha{7}, U. Landmesser{8}, E. Leitersdorf{9}, R. Morishita{10}, K. Wolski{11}, Z. Zhao{12}, V. Menon{13}, J. McCluskey{2}, I. Gouni-Berthold{14}, R. Santos{15}, B. Manning{16}, J. Wang{16}, A. Lesogor{17}, H. Cao{16}, B. Nordestgaard{18};
{1}C5Research at Cleveland Clinic, Cleveland, OH, {2}Cleveland Clinic, Cleveland, OH, {3}Monash University, Clayton, Australia, {4}C5Research at Cleveland Clinic, Mentor, OH, {5}Cleveland Clinic, Bentleyville, OH, {6}University of California, San Diego, Rancho Santa Fe, CA, {7}Johns Hopkins Hospital, Baltimore, MD, {8}DZHK, Berlin, Germany, {9}Hadassah University Hospital, Jersualem, Israel, {10}Osaka University Medical School, Suita City, Japan, {11}Cleveland, Cleveland, OH, {12}China Novartis Institutes for BioMedical Research, Shanghai, China, {13}C5Research and Cleveland Clinic, Cleveland, OH, {14}University Clinic of Cologne, Bonn, Germany, {15}Hospital Israelita Albert Einstein and University of Saão Paulo, São Paulo, Brazil, {16}Novartis Pharmaceuticals, East Hanover, NJ, {17}Novartis Pharma AG, Basel, Switzerland, {18}Copenhagen Univerity Hopsital, Herlev, Denmark